Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects and Cost-Effectiveness of Pharmacogenetic Screening Among Elderly Starters With Antidepressants: A Pragmatic Randomized Controlled Trial

NCT01778907 is registered in ClinicalTrials.gov with University of Groningen as lead sponsor.

NCT NCT01778907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01778907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects and Cost-Effectiveness of Pharmacogenetic Screening Among Elderly Starters With Antidepressants: A Pragmatic Randomized Controlled Trial
Lead sponsor
University of Groningen
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2013
Completion date
June 30, 2017
Enrollment
202 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depressive disorder, intermediate metabolizer due to cytochrome p450 cyp2d6 variant, poor metabolizer due to cytochrome p450 cyp2d6 variant, ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant